Skip directly to content

Bosulif® ▼ (bosutinib monohydrate)

For more information on this product please visit the electronic Medicines Compendium (eMC)

▼ This medicine is subject to additional monitoring.

If you get any side effects when taking this or any other medicine, talk to your doctor or other relevant health professional e.g. pharmacist, nurse. This includes any possible side effects not listed in the packaging leaflet. You can also report side effects directly via the Yellow Card Scheme at By reporting side effects, you can help provide more information on the safety of this medicine.

Pfizer is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professional for specific, health-related advice and support.

PP-BOS-GBR-0865 / Oct 2019